Apart from the previously noted findings, there was a marked reduction in Collagen-I levels in skeletal muscle after MSTN-ASO treatment, suggesting an alleviation of muscle fibrosis—a secondary but critical aspect of CKD-induced sarcopenia. Here, MSTN is linked to sarcopenia.